Russell Investments Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Russell Investments Group’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-58,958	Closed	-$2.79M	–	3099
2017 Q4	$2.79M	Buy	58,958 +39,719	+206%	+$1.98M	﹤0.01%	1660
2017 Q3	$864K	Buy	19,239 +1,555	+9%	+$53K	﹤0.01%	2214
2017 Q2	$528K	Buy	17,684 +6,943	+65%	+$171K	﹤0.01%	2390
2017 Q1	$238K	Hold	10,741	–	–	﹤0.01%	2657
2016 Q4	$204K	Buy	+10,741	New	+$263K	﹤0.01%	2716

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Russell Investments Group's JUNO Position: Q1 2018 in Review

Russell Investments Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 58,958 shares — an estimated $2.79M sold.

Russell Investments Group first reported a position in JUNO in Q4 2016 and held it in 5 quarters. The position peaked at $2.79M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Russell Investments Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Russell Investments Group sold 58,958 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.79M.
Russell Investments Group first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
Russell Investments Group's Juno Therapeutics, Inc. position peaked at $2.79M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Russell Investments Group's 13F filing for Q1 2018, filed 11 May 2018.